Montefiore Einstein sees lowest rate of late-stage lung cancer diagnoses in surrounding community

Lung cancer drug offers a surprising new treatment against ovarian cancer, Mayo study finds

Ovarian cancer cells may quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better, a study published by Mayo Clinic researchers suggests.

February 20, 2026

Vol.52 No.07

Cancer Policy

Tens of thousands of healthcare workers strike across the country

Around 31,000 healthcare workers in California and Hawaii joined the picket line Jan. 26 as the United Nurses Associations of California/Union of Health Care  Professionals and Kaiser Permanente reached an impasse in contract negotiations.

January 30, 2026

Vol.52 No.04

By Sara Willa Ernst

Clinical Trials & Tribulations

A radiation oncologist’s perspective: Why we need to accelerate early detection strategies for lung cancers

As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease. The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...

January 16, 2026

Vol.52 No.02

By Kevin King

Clinical Trials & Tribulations

How a Montefiore Einstein screening program is changing the history of lung cancer in the Bronx

Lung cancer remains the leading cause of cancer death in the United States, largely because it is most often diagnosed at an advanced stage.

Blood test detects lung cancer up to 5 years before scans, Personalis and University College London study finds

Personalis Inc. announced the publication of one of the largest and most comprehensive patient cohorts to date from the landmark TRACERx study, which demonstrated the clinical importance of ultrasensitive, tumor-informed molecular residual disease testing in stage 1 to 3 non-small cell lung cancer.

December 19, 2025

Vol.51 No.46

Podcast

Roy Herbst remembers the late Edward Chu, “the baritone of reason” and “a gentle giant”

Edward Chu, director of the Montefiore Einstein Comprehensive Cancer Center, died on Nov. 13 from glioblastoma. He was 66.

December 03, 2025

Vol.51 No.43

Montefiore Einstein sees lowest rate of late-stage lung cancer diagnoses in surrounding community

YOU MAY BE INTERESTED IN

Lung cancer drug offers a surprising new treatment against ovarian cancer, Mayo study finds

Tens of thousands of healthcare workers strike across the country

A radiation oncologist’s perspective: Why we need to accelerate early detection strategies for lung cancers

How a Montefiore Einstein screening program is changing the history of lung cancer in the Bronx

Blood test detects lung cancer up to 5 years before scans, Personalis and University College London study finds

Roy Herbst remembers the late Edward Chu, “the baritone of reason” and “a gentle giant”

Renew today!

Subscriber content

Never miss an issue!

Login